As the world faces the global pandemic, it has affected all the parameters
world-wide and the permanent solution to get the human life back from
stand-still is to progress with a successful vaccine. For the development of a
successful vaccine, it has to undergo five stages- the first stage comprises of
the exploratory phase which involves laboratory research and methodologies to
encompass the strategies into the area, thereafter pre-clinical stage, to find
out more about the intervention, clinical development which consists of four
phases, followed by approval stage and the last stage being the manufacturing
process and quality control. In order to derive a remedy for the same, every
other company is in the race to find the vaccine.
Need to develop a vaccine
Due to the outbreak of novel corona virus, many industry sectors have been
negatively affected including tourism and aviation, entrepreneurs, hospitality,
automobiles, media and entertainment, railways and real estate. The economies of
the world have been hit tremendously and people have faced unemployment, laying
off and lack of funds to fulfil their basic necessities. It has brought shock to
the entire working system causing changes to the lifestyle of the individuals.
Recognizing the urgent need to develop a safe and effective vaccine for Covid-19
by collaborating with the researchers, scientists and pharmaceutical companies.
Should vaccine be patented or kept generic?
Considering the resources, infrastructure and the man-power used in the research
process for the development of the vaccine, such gathered efforts by the
pharmaceutical institutions enable them to access the patent rights. The
companies who develop the vaccine impose potential threat on their intellectual
property as it may lead to duplication and generic manufacturing of the same
products by local drug store at a cheaper rate and counterfeiting of the
products. So to remove the structural barrier and to avoid infringement of drug,
it becomes necessary to obtain patent rights over the production of the vaccine.
The upcoming vaccines will also have a benefit of patent protection towards wide
Section 53 of Patents Act 1970 states that:
the tenure of protection of patent is twenty years from the date of filing of
the application for the patent�, thus this will make the owners not only protect
the product but also remove competition which will make them a superpower in the
market to supersede as a monopoly and can demand the price as they seem fit.
Also these institutions will be able to recover their preliminary expenses after
the grant of patent.
On the other hand, it has been of peremptory measure to make the vaccine
available to the public. This will have an immediate effect throughout the globe
and it would also socially benefit all the developing countries at affordable
prices. Moderna President Stephen Hoge said in an interview, We're not
interested in using that IP to decrease the number of vaccines available in a
Also once a vaccine is developed by a country, the patent protection will be
available for 20 years and other companies can only use the vaccine once the
tenure ends, thus the process research and development to obtaining the patent
rights is a lengthy and time consuming process. The world has entered into
global inter dependencies which requires integrated measures to overcome the
crisis. An individual may be rich or poor, insured or uninsured, he/she should
be protected from the clutches of Coronavirus.
With respect to Article 21 of the Indian Constitution, every person has a right
to life or personal liberty. Taking into account the current scenario, safety of
the people is of utmost importance rather than being profit oriented. This in
turn will lead to mass production and availability would not be a concern.
In accordance to the global efforts and complexities to develop and distribute
the vaccine, and also considering the domestic legal issues one solution to this
dilemma is that the government can initiate by providing monetary rewards to
research and development institutions and pharmaceutical companies instead of
them applying for the patent, in order to encourage the scientists and
researchers to strive towards Excellency. Thus, to derive a vaccine,
pharmaceuticals should keep in mind the aspects for betterment of the world
rather than solely focusing on their profit and improvement.